Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
- February -
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
- 2023 -
2024
-
2025
February 2023 - 53 products
IP
Lunsumio 1 mg/1 ml
232.71
269.50
10 %
Concentrate for infusion: Mosunetuzumabum 1 mg/ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
IP
Lunsumio 30 mg/30 ml
6981.30
7470.60
10 %
Concentrate for infusion: Mosunetuzumabum 30mg / 30ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
IP
CI
Ovamex
PR
PR
k.A.
Injection solution in prefilled syringe: Ganirelixum
Future Health Pharma
GmbH
A
FB
G
IP
CI
Ovamex
5
PR
PR
k.A.
Injection solution in prefilled syringe: Ganirelixum
Future Health Pharma
GmbH
A
FB
G
L
IP
V/S
Vaxneuvance
58.28
79.80
10 %
Injection suspension: 10 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
L
IP
V/S
Vaxneuvance
10
582.80
650.25
10 %
Injection suspension: 10 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
Ibu-Fairmed 200 mg
10
PR
PR
k.A.
Soft capsules: Ibuprofenum 200 mg
Strides Pharma
International AG
D
FB
G
Ibu-Fairmed 200 mg
20
PR
PR
k.A.
Soft capsules: Ibuprofenum 200 mg
Strides Pharma
International AG
D
FB
G
Ibu-Fairmed 400 mg
10
PR
PR
k.A.
Soft capsules: Ibuprofenum 400 mg
Strides Pharma
International AG
D
FB
G
IP
CI
Ryeqo
28
PR
PR
k.A.
Coated tablets: 3 Active Agents
Gedeon Richter
(Schweiz) AG
B
FB
G
IP
CI
Ryeqo
84
PR
PR
k.A.
Coated tablets: 3 Active Agents
Gedeon Richter
(Schweiz) AG
B
FB
G
IP
CI
Ryeqo
28
PR
PR
k.A.
Coated tablets: 3 Active Agents
Gedeon Richter
(Schweiz) AG
B
FB
G
IP
CI
Ryeqo
84
PR
PR
k.A.
Coated tablets: 3 Active Agents
Gedeon Richter
(Schweiz) AG
B
FB
G
Ciferavit D3 zur Therapie
30 ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 4000 UI/ml
Medius AG
B
FB
G
Ciferavit D3 zur
Prophylaxe
10 ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 4000 UI/ml
Medius AG
D
FB
G
Valverde Intestomint
15
PR
PR
k.A.
: Menthae Piperitae Aetheroleum (Mentha X Piperita l., Aetheroleum) 182 mg
Uriach Switzerland AG
D
FB
G
Valverde Intestomint
60
PR
PR
k.A.
: Menthae Piperitae Aetheroleum (Mentha X Piperita l., Aetheroleum) 182 mg
Uriach Switzerland AG
D
FB
G
IP
CI
Levina 30
21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Levina 30
3 x 21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Levina 30
6 x 21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
Pluvicto 1000 MBq/ml
PR
PR
k.A.
Infusion solution: Lutetium(177lu) Vipivotidum Tetraxetanum 1000 MBq/ml
Novartis Pharma
Schweiz AG
A
FB
G
IP
CI
Ezetimib Rosuvastatin
Sandoz 10 mg / 5 mg
30 mg
PR
PR
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Ezetimib Rosuvastatin
Sandoz 10 mg / 5 mg
90 mg
PR
PR
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
L
IP
Ezetimib Rosuvastatin
Sandoz 10 mg / 10 mg
30 mg
18.97
37.05
10 %
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / SL
FB
G
L
IP
Ezetimib Rosuvastatin
Sandoz 10 mg / 10 mg
90 mg
54.81
76.05
10 %
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / SL
FB
G
L
IP
Ezetimib Rosuvastatin
Sandoz 10 mg / 20 mg
30 mg
20.77
39.00
10 %
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / SL
FB
G
L
IP
Ezetimib Rosuvastatin
Sandoz 10 mg / 20 mg
90 mg
60.13
81.80
10 %
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / SL
FB
G
IP
CI
Amlodipin Zentiva 5 mg
30
6.89
16.75
10 %
Tablets: Amlodipinum 5 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Amlodipin Zentiva 5 mg
100
17.86
35.85
10 %
Tablets: Amlodipinum 5 mg
Helvepharm AG
●
B / SL / SG
FB
G
IP
Amlodipin Zentiva 10 mg
30
10.55
27.85
10 %
Tablets: Amlodipinum 10 mg
Helvepharm AG
B / SL / SG
FB
G
IP
Amlodipin Zentiva 10 mg
100
34.85
54.35
10 %
Tablets: Amlodipinum 10 mg
Helvepharm AG
●
B / SL / SG
FB
G
CI
Valverde Magen-Darm
10
PR
PR
k.A.
Coated tablets: Millefolii Herbae Extractum Aquosum Siccum (Achillea Millefolium l., Herba) 250 mg
Uriach Switzerland AG
D
FB
G
CI
Valverde Magen-Darm
30
PR
PR
k.A.
Coated tablets: Millefolii Herbae Extractum Aquosum Siccum (Achillea Millefolium l., Herba) 250 mg
Uriach Switzerland AG
D
FB
G
CI
Valverde Magen-Darm
60
PR
PR
k.A.
Coated tablets: Millefolii Herbae Extractum Aquosum Siccum (Achillea Millefolium l., Herba) 250 mg
Uriach Switzerland AG
D
FB
G
CI
Adler Juvebene
400
PR
PR
k.A.
Tablets: 4 Active Agents
Adler Pharma Helvetia AG
D
FB
G
CI
Adler Juvebene
1000
PR
PR
k.A.
Tablets: 4 Active Agents
Adler Pharma Helvetia AG
D
FB
G
L
IP
Elzonris 1mg / ml
16243.50
16973.65
10 %
Concentrate for infusion: Tagraxofuspum 1 mg/ml
Stemline Therapeutics
Switzerland GmbH
A / SL
FB
G
Ticagrelor Zentiva 60 mg
56
PR
PR
k.A.
Coated tablets: Ticagrelorum 60 mg
Helvepharm AG
B
FB
G
Ticagrelor Zentiva 60 mg
168
PR
PR
k.A.
Coated tablets: Ticagrelorum 60 mg
Helvepharm AG
B
FB
G
Ticagrelor Zentiva 90 mg
56
PR
PR
k.A.
Coated tablets: Ticagrelorum 90 mg
Helvepharm AG
B
FB
G
Ticagrelor Zentiva 90 mg
98
PR
PR
k.A.
Coated tablets: Ticagrelorum 90 mg
Helvepharm AG
B
FB
G
Ticagrelor Zentiva 90 mg
168
PR
PR
k.A.
Coated tablets: Ticagrelorum 90 mg
Helvepharm AG
B
FB
G
L
IP
CI
Deferasirox Spirig HC 90 mg
30
143.41
172.40
10 %
Coated tablets: Deferasiroxum 90 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Deferasirox Spirig HC 90 mg
90
365.68
414.10
10 %
Coated tablets: Deferasiroxum 90 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Deferasirox Spirig HC 180 mg
30
235.19
272.20
10 %
Coated tablets: Deferasiroxum 180 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Deferasirox Spirig HC 180 mg
90
599.72
668.65
10 %
Coated tablets: Deferasiroxum 180 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Deferasirox Spirig HC 360 mg
30
385.70
435.90
10 %
Coated tablets: Deferasiroxum 360 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Deferasirox Spirig HC 360 mg
90
983.53
1086.05
10 %
Coated tablets: Deferasiroxum 360 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Deferasirox Spirig HC 900 mg
30
790.68
876.35
10 %
Coated tablets: Deferasiroxum 900 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Deferasirox Spirig HC 900 mg
90
2016.23
2209.20
10 %
Coated tablets: Deferasiroxum 900 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Pluvicto CA 1000 MBq/ml
PR
PR
k.A.
Infusion solution: Lutetium(177lu(Ca)) Vipivotidum Tetraxetanum 1000 MBq/ml
Novartis Pharma
Schweiz AG
A
FB
G
L
IP
Vegzelma 100 mg/4 ml
257.57
296.55
10 %
Concentrate for infusion: Bevacizumabum 100mg / 4ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
Vegzelma 400 mg/16 ml
962.84
1063.55
10 %
Concentrate for infusion: Bevacizumabum 400mg / 16ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
